10x Genomics (TXG) Change in Cash (2018 - 2026)

10x Genomics has disclosed Change in Cash across 9 years of filings, most recently posting $16.3 million for Q1 2026.

• Change in Cash for Q1 2026 came in at $16.3 million, down 50.54% year-over-year; the trailing twelve-month figure through Mar 2026 was $113.2 million (up 432.07% YoY), and the FY2025 annual result was $129.9 million, up 953.64% from the prior year.
• Change in Cash came in at $16.3 million for Q1 2026 at 10x Genomics, down from $41.3 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $112.4 million in Q1 2023 to a low of -$276.0 million in Q1 2022.
• The 5-year median for Change in Cash is $16.3 million (2026), against an average of -$6.2 million.
• Across the five-year window, Change in Cash slumped 906.61% in 2022 and soared 1041.88% in 2025, its largest moves.
• 10x Genomics' Change in Cash stood at -$14.2 million in 2022, then jumped by 413.77% to $44.5 million in 2023, then slumped by 221.43% to -$54.1 million in 2024, then soared by 176.27% to $41.3 million in 2025, then tumbled by 60.45% to $16.3 million in 2026.
• The last three Change in Cash figures came in at $16.3 million (Q1 2026), $41.3 million (Q4 2025), and $35.0 million (Q3 2025), per Business Quant data.